The Therapeutic Goods Administration has released new support materials specifically for pharmacists to use when engaging with customers about the forthcoming rescheduling of codeine-containing products.
The content includes a special pharmacist fact sheet detailing the reasons for the change, support for
clinical decisions about alternative pain treatments and a warning about stockpiling the products.
Click here to see more information.
Source: pharmacydaily.com.au, Friday 14 July 2017